Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain
Titel:
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain
Auteur:
Somersan-Karakaya, Selin Turner, Kenneth C. Cortes-Burgos, Luz Miller, Jutta LaCroix-Fralish, Michael Logovinsky, Veronika Patel, Yamini Torres, Richard Ganguly, Samit Breazna, Aurora DeVeaux, Michelle Bhore, Rafia Gao, Min Delfino, Frank J. Rafique, Ashique Fairhurst, Jeanette L. Hunt, Charleen Babb, Robert Badithe, Ashok Poueymirou, William T. Surowitz, Ronald Rottey, Sylvie Murphy, Andrew J. Harari, Olivier Macdonald, Lynn E. Croll, Susan D.